Skip to main content

Day: September 24, 2024

CARBIOS and Selenis announce strategic partnership to produce PETG issued from CARBIOS’ biorecycling technology for Cosmetic and Healthcare markets

CARBIOS – PET Biorecycling – MEGMEG monomer from CARBIOS’ PET biorecycling processCARBIOS – PET Biorecycling – PTAPTA monomer from CARBIOS’ PET biorecycling processAerial view of Selenis’ industrial plant in Portalegre, PortugalAerial view of Selenis’ industrial plant in Portalegre, PortugalClermont-Ferrand (France), Tuesday 24 September 2024 (6pm CEST). – CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization,...

Continue reading

Eurobio Scientific: RESULTS FOR THE 1ST HALF OF 2024

RESULTS FOR THE 1ST HALF OF 2024Revenues up 12% on a like-for-like basis (24% overall) Stable adjusted EBITDA1 and operating profit Net financial debt down slightly to €1.6m, with cash of €86.6m Proposed voluntary takeover bidParis, September 24, 2024 – 6pm – Eurobio Scientific (FR0013240934, ALERS), a leading French group in in vitro medical diagnostics and life sciences, today announced its consolidated annual results at June 30, 2024, prepared under French GAAP and approved by the company’s Board of Directors at its meeting on September 24, 2024. Eurobio Scientific’s results at June 30, 2024 show relative stability, with growth in sales offset by a slight fall in gross margin rate and an increase in expenses.in €m June 30, 2024 June 30, 2023   ChangeRevenues 73.1 59.2   +23%R&D subsidies and...

Continue reading

Transgene to Report Major Clinical Data before the end of 2024 – Confirmed Financial Visibility until Q4 2025

2024 Half-Year Results and Business Update Lead program TG4050 (individualized immunotherapy): – First signs of clinical benefit in adjuvant head and neck cancer reported at AACR 2024, paved the way for the start of Phase II part of randomized Phase I/II clinical trial in Q2 2024 – Median 24-month follow-up data to be presented in Q4 2024 BT-001 (oncolytic virus): Data presented at ESMO (Sept. 2024) showed promising antitumor activity in solid tumors that failed previous anti-PD(L)-1 treatment TG4001 (HPV therapeutic cancer vaccine): Randomized Phase II study expected to read out in Q4 2024 Financial visibility confirmed until Q4 2025 Conference call scheduled today at 6 p.m. CET (in English). See details below. Strasbourg, France, September 24, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and...

Continue reading

Availability of Transgene’s Half-Year Financial Report as of June 30, 2024

TRANSGENE (Paris: TNG) today announced that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2024. The document is available on the Company’s website: www.transgene.fr, in the “Investors/Financial information” section. This report comprises the following documents:2024 half-year financial statements; Half-year management report; Statutory Auditors’ report on the 2024 half-year financial statements; Declaration by the person responsible for this half-year financial report.ContactsMedia: Caroline Tosch Responsable Communication Corporate +33 3 68 33 27 38 communication@transgene.fr   Investisseurs : Nadège Bartoli Chargée relations investisseurs +33 3 88 27 91 03 Lucie Larguier Directrice Financière +33 3 88 27 91 00 investorrelations@transgene.fr ...

Continue reading

LUMIBIRD: FIRST-HALF RESULTS FOR 2024 UP IN THE MEDICAL DIVISION, LOWER IN THE PHOTONICS DIVISION

Lannion, September 24, 2024 – 17:45 pm FIRST-HALF RESULTS FOR 2024 UP IN THE MEDICAL DIVISION, LOWER IN THE PHOTONICS DIVISIONEBITDA1 of €10.9m on a reported basis, compared with €13.8m in H1 2023Medical Division: EBITDA as a percentage of sales revenue up to 17.6% (vs. 15.4% in H1 2023) Photonics division: EBITDA as a percentage of sales revenue down to 4.3% (vs 12.9% in H1 2023) and 7.9% excluding ConvergentLumibird expects to achieve sales revenue growth of over 5% and an EBITDA as a percentage of sales revenue of over 16% in 20243-year objectives of 2024-2026 plan maintainedThe Lumibird Group, the European leader in laser technologies, has published lower results for the first half of 2024, due to a fall in profitability in the Photonics division, mainly because of lower-than-expected sales, an unfavourable product...

Continue reading

Belltopper Mineralisation Modelling Defines Prospectivity

HIGHLIGHTSBelltopper Gold Project Exploration Target defined. Belltopper is located within the gold prolific Bendigo Tectonic Zone in Victoria and approximately 50 km SSW of the high-grade world-class Fosterville Gold Mine. The Exploration Target was defined through geological modelling of priority target reefs following completion of 2024 drilling and the release of assay results. The Exploration Target excludes numerous emerging prospective zones and conceptual targets based on progressive geological and geochemical understanding. Evolving geology model provides multiple, high priority, drill-ready targets. Diverse range of mineralisation styles demonstrated by current work programs. Potential for Intrusion Hosted/Intrusion Related mineralisation and Fosterville-style, world-class, high-grade gold to be tested in forward drill programs.VANCOUVER,...

Continue reading

Casella Waste Systems, Inc. Highlights Investments in its People, Recycling Infrastructure, and Communities in 2024 Sustainability Report (Updated)

Casella 2024 Sustainability Report CoverCasella’s 2024 Sustainability Report highlights investments in its people, infrastructure, and communities leading to progress towards 2030 goals.Every day is an opportunity to create change, to have an impact, to make a difference. Every day is an opportunity to care for the world around us, our communities, and each other. Every day is an opportunity to walk the path of sustainability.Casella is right there with you every step of the way.Together, we are making a difference.RUTLAND, Vt., Sept. 24, 2024 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (Nasdaq: CWST) (“Casella,” the “Company”) published its 2024 Sustainability Report today, outlining its progress toward five key sustainability metrics, while highlighting significant achievements in several...

Continue reading

Shipsi Acquired by Rainmakers in Bid to Redefine Shipping Speeds and Disrupt Traditional E-Commerce Logistics

Shipsi gives any retailer the power to offer customers instant one-hour delivery MIAMI, Sept. 24, 2024 (GLOBE NEWSWIRE) — Rainmakers today announced it had acquired the on-demand delivery and logistics technology, Shipsi, from Auctane. Shipsi is the technology leveling the “instant shipping” playing field in retail. Shipsi believes this acquisition will usher in a new era of AI-driven, ultra-fast delivery solutions for retailers of all sizes and looks forward to continuing to enhance its ability to transform retail logistics through ongoing innovation and support from trusted partners, ensuring a seamless and improved experience for both retailers and consumers. Shipsi’s technology gives retailers the power to offer same-day shipping by mobilizing last-mile networks to deliver goods. To date, Shipsi has given thousands...

Continue reading

Court Approves Complete Solar Purchase of SunPower Assets

LEHI, Utah, Sept. 24, 2024 (GLOBE NEWSWIRE) — Complete Solar Holdings, Inc. d/b/a Complete Solar (“Complete Solar” or the “Company”) (Nasdaq: CSLR), a solar technology, services, and installation company, today announced that the United States Bankruptcy Court for the District of Delaware has approved the going concern sale of substantially all assets of the Blue Raven, New Homes and Dealer businesses of SunPower Corporation and certain of its affiliates to Complete Solar for $45 million in cash. The sale is expected to close on or before Monday, September 30, 2024, at which time SunPower businesses, the SunPower brand, and about 1,000 employees will become part of Complete Solar, the temporary name of SunPower during this transition. T.J. Rodgers, Complete Solar’s CEO, commented “This is a pivotal moment in the history of SunPower,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.